相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。On a Statistical Transmission Model in Analysis of the Early Phase of COVID-19 Outbreak
Yifan Zhu et al.
STATISTICS IN BIOSCIENCES (2021)
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
Manli Wang et al.
CELL RESEARCH (2020)
Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target
Haibo Zhang et al.
INTENSIVE CARE MEDICINE (2020)
Air, Surface Environmental, and Personal Protective Equipment Contamination by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) From a Symptomatic Patient
Sean Wei Xiang Ong et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Presumed Asymptomatic Carrier Transmission of COVID-19
Yan Bai et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus
Calvin J. Gordon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
The Role of Augmented Intelligence (AI) in Detecting and Preventing the Spread of Novel Coronavirus
Justin B. Long et al.
JOURNAL OF MEDICAL SYSTEMS (2020)
Development and clinical application of a rapid IgM-IgG combined antibody test for SARS-CoV-2 infection diagnosis
Zhengtu Li et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Genomic variance of the 2019-nCoV coronavirus
Carmine Ceraolo et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Combination of RT-qPCR testing and clinical features for diagnosis of COVID-19 facilitates management of SARS-CoV-2 outbreak
Yishan Wang et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Clinical Characteristics of Coronavirus Disease 2019 in China
W. Guan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients
Lirong Zou et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
A Novel Coronavirus from Patients with Pneumonia in China, 2019
Na Zhu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection
Emmie de Wit et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV
Timothy P. Sheahan et al.
NATURE COMMUNICATIONS (2020)
Comparative genetic analysis of the novel coronavirus (2019-nCoV/SARS-CoV-2) receptor ACE2 in different populations
Yanan Cao et al.
CELL DISCOVERY (2020)
The outbreak of SARS-CoV-2 pneumonia calls for viral vaccines
Weilong Shang et al.
NPJ VACCINES (2020)
Insights into the Recent 2019 Novel Coronavirus (SARS-CoV-2) in Light of Past Human Coronavirus Outbreaks
Hossam M. Ashour et al.
PATHOGENS (2020)
Is BCG vaccination affecting the spread and severity of COVID-19?
Cevdet Ozdemir et al.
ALLERGY (2020)
Spike protein recognition of mammalian ACE2 predicts the host range and an optimized ACE2 for SARS-CoV-2 infection
Junwen Luan et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
The Architecture of SARS-CoV-2 Transcriptome
Dongwan Kim et al.
CELL (2020)
Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2
Vanessa Monteil et al.
CELL (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
Rational Use of Tocilizumab in the Treatment of Novel Coronavirus Pneumonia
Shengyu Zhang et al.
CLINICAL DRUG INVESTIGATION (2020)
Whole genome and phylogenetic analysis of two SARS-CoV-2 strains isolated in Italy in January and February 2020: additional clues on multiple introductions and further circulation in Europe
Paola Stefanelli et al.
EUROSURVEILLANCE (2020)
Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study
Xiaobo Yang et al.
Lancet Respiratory Medicine (2020)
Cytokine storm and immunomodulatory therapy in COVID-19: Role of chloroquine and anti-IL-6 monoclonal antibodies
Ming Zhao
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality
Chi Zhang et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
Philippe Gautret et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
A Review of SARS-CoV-2 and the Ongoing Clinical Trials
Yung-Fang Tu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma
Chenguang Shen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Active Monitoring of Persons Exposed to Patients with Confirmed COVID-19-United States, January-February 2020
Rachel M. Burke et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)
On the origin and continuing evolution of SARS-CoV-2
Xiaolu Tang et al.
NATIONAL SCIENCE REVIEW (2020)
Phylogenetic network analysis of SARS-CoV-2 genomes
Peter Forster et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Effectiveness of convalescent plasma therapy in severe COVID-19 patients
Kai Duan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2)
Ruiyun Li et al.
SCIENCE (2020)
Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies
Jianjun Gao et al.
BIOSCIENCE TRENDS (2020)
Tocilizumab: A new opportunity in the possible therapeutic arsenal against COVID-19
Yeimer Ortiz-Martinez
TRAVEL MEDICINE AND INFECTIOUS DISEASE (2020)
Airborne Transmission Route of COVID-19: Why 2 Meters/6 Feet of Inter-Personal Distance Could Not Be Enough
Leonardo Setti et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2020)
Emerging SARS-CoV-2 mutation hot spots include a novel RNA-dependent-RNA polymerase variant
Maria Pachetti et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2020)
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
Yeming Wang et al.
LANCET (2020)
Seasonality of Respiratory Viral Infections
Miyu Moriyama et al.
ANNUAL REVIEW OF VIROLOGY, VOL 7, 2020 (2020)
WITHDRAWN: Is global BCG vaccination coverage relevant to the progression of SARS-CoV-2 pandemic?
Mayda Gursel et al.
MEDICAL HYPOTHESES (2020)
Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) - United States, February 12-March 16, 2020
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)
Favorable changes of CT findings in a patient with COVID-19 pneumonia after treatment with tocilizumab
M. Cellina et al.
DIAGNOSTIC AND INTERVENTIONAL IMAGING (2020)
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
David E. Gordon et al.
NATURE (2020)
The pandemic pipeline
John Hodgson
NATURE BIOTECHNOLOGY (2020)
Fast, portable tests come online to curb coronavirus pandemic
Cormac Sheridan
NATURE BIOTECHNOLOGY (2020)
Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2
Yadi Zhou et al.
CELL DISCOVERY (2020)
The proximal origin of SARS-CoV-2
Kristian G. Andersen et al.
NATURE MEDICINE (2020)
SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes
Waradon Sungnak et al.
NATURE MEDICINE (2020)
The COVID-19 vaccine development landscape
Tung Thanh Le et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study
Qingxian Cai et al.
ENGINEERING (2020)
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19
B. Cao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Compassionate Use of Remdesivir for Patients with Severe Covid-19
J. Grein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1
Neeltje van Doremalen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Airborne transmission of SARS-CoV-2: The world should face the reality
Lidia Morawska et al.
ENVIRONMENT INTERNATIONAL (2020)
No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection
J. M. Molina et al.
MEDECINE ET MALADIES INFECTIEUSES (2020)
Association between climate variables and global transmission oF SARS-CoV-2
Marcos Felipe Falcao Sobral et al.
SCIENCE OF THE TOTAL ENVIRONMENT (2020)
Impact of temperature on the dynamics of the COVID-19 outbreak in China
Peng Shi et al.
SCIENCE OF THE TOTAL ENVIRONMENT (2020)
High Contagiousness and Rapid Spread of Severe Acute Respiratory Syndrome Coronavirus 2
Steven Sanche et al.
EMERGING INFECTIOUS DISEASES (2020)
Genomic characterization of a novel SARS-CoV-2
Rozhgar A. Khailany et al.
GENE REPORTS (2020)
Stability of SARS-CoV-2 in different environmental conditions
Alex W. H. Chin et al.
LANCET MICROBE (2020)
Case of the Index Patient Who Caused Tertiary Transmission of Coronavirus Disease 2019 in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Pneumonia Monitored by Quantitative RT-PCR
Jaegyun Lim et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2020)
Early Epidemiological and Clinical Characteristics of 28 Cases of Coronavirus Disease in South Korea
Insik Kong et al.
OSONG PUBLIC HEALTH AND RESEARCH PERSPECTIVES (2020)
Viral Metagenomics Revealed Sendai Virus and Coronavirus Infection of Malayan Pangolins (Manis javanica)
Ping Liu et al.
VIRUSES-BASEL (2019)
Challenges of convalescent plasma infusion therapy in Middle East respiratory coronavirus infection: a single centre experience
Jae-Hoon Ko et al.
ANTIVIRAL THERAPY (2018)
Nextstrain: real-time tracking of pathogen evolution
James Hadfield et al.
BIOINFORMATICS (2018)
Why are RNA virus mutation rates so damn high?
Siobain Duffy
PLOS BIOLOGY (2018)
RNA Virus Fidelity Mutants: A Useful Tool for Evolutionary Biology or a Complex Challenge?
Tiffany F. Kautz et al.
VIRUSES-BASEL (2018)
1,2,3-Triazolyl ester of Ketorolac: A Click Chemistry-based highly potent PAK1-blocking cancer-killer
Binh Cao Quan Nguyen et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Zinc Salts Block Hepatitis E Virus Replication by Inhibiting the Activity of Viral RNA-Dependent RNA Polymerase
Nidhi Kaushik et al.
JOURNAL OF VIROLOGY (2017)
Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase
Yousuke Furuta et al.
PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES (2017)
Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses
Timothy P. Sheahan et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
The not-so-infinite malleability of RNA viruses: Viral and cellular determinants of RNA virus mutation rates
Everett Clinton Smith
PLOS PATHOGENS (2017)
Chloroquine, a FDA-approved Drug, Prevents Zika Virus Infection and its Associated Congenital Microcephaly in Mice
Chunfeng Li et al.
EBIOMEDICINE (2017)
GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and Paramyxoviruses
Michael K. Lo et al.
SCIENTIFIC REPORTS (2017)
Frondoside A from sea cucumber and nymphaeols from Okinawa propolis: Natural anti-cancer agents that selectively inhibit PAK1 in vitro
Binh Cao Quan Nguyen et al.
DRUG DISCOVERIES AND THERAPEUTICS (2017)
Anti-inflammatory activity of chloroquine and amodiaquine through p21-mediated suppression of T cell proliferation and Th1 cell differentiation
Sera Oh et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Chloroquine could be used for the treatment of filoviral infections and other viral infections that emerge or emerged from viruses requiring an acidic pH for infectivity
Hephzibah Akpovwa
CELL BIOCHEMISTRY AND FUNCTION (2016)
RNA Recombination Enhances Adaptability and Is Required for Virus Spread and Virulence
Yinghong Xiao et al.
CELL HOST & MICROBE (2016)
Structure, Function, and Evolution of Coronavirus Spike Proteins
Fang Li
ANNUAL REVIEW OF VIROLOGY, VOL 3 (2016)
Chloroquine inhibited Ebola virus replication in vitro but failed to protect against infection and disease in the in vivo guinea pig model
Stuart D. Dowall et al.
JOURNAL OF GENERAL VIROLOGY (2015)
Treatment With Lopinavir/Ritonavir or Interferon-β1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset
Jasper Fuk-Woo Chan et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Phosphonooxymethyl Prodrug of Triptolide: Synthesis, Physicochemical Characterization, and Efficacy in Human Colon Adenocarcinoma and Ovarian Cancer Xenografts
Satish Patil et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Bat-to-human: spike features determining 'host jump' of coronaviruses SARS-CoV, MERS-CoV, and beyond
Guangwen Lu et al.
TRENDS IN MICROBIOLOGY (2015)
Novel Fluorinated 8-Hydroxyquinoline Based Metal Ionophores for Exploring the Metal Hypothesis of Alzheimer's Disease
Steven H. Liang et al.
ACS MEDICINAL CHEMISTRY LETTERS (2015)
Screening of an FDA-Approved Compound Library Identifies Four Small-Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Replication in Cell Culture
Adriaan H. de Wilde et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Coronaviruses Induce Entry-Independent, Continuous Macropinocytosis
Megan Culler Freeman et al.
MBIO (2014)
Coronavirus Cell Entry Occurs through the Endo-/Lysosomal Pathway in a Proteolysis-Dependent Manner
Christine Burkard et al.
PLOS PATHOGENS (2014)
Synergistic combinations of favipiravir and oseltamivir against wild-type pandemic and oseltamivir-resistant influenza A virus infections in mice
Donald F. Smee et al.
FUTURE VIROLOGY (2013)
Development of novel entry inhibitors targeting emerging viruses
Yanchen Zhou et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2012)
Mechanisms of Coronavirus Cell Entry Mediated by the Viral Spike Protein
Sandrine Belouzard et al.
VIRUSES-BASEL (2012)
Role of the p21-activated kinases (PAKs) in influenza A virus replication
Philippe None Q. Pascua et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Convalescent Plasma Treatment Reduced Mortality in Patients With Severe Pandemic Influenza A (H1N1) 2009 Virus Infection
Ivan F. N. Hung et al.
CLINICAL INFECTIOUS DISEASES (2011)
SARS-CoV and emergent coronaviruses: viral determinants of interspecies transmission
Meagan Bolles et al.
CURRENT OPINION IN VIROLOGY (2011)
Effects of Air Temperature and Relative Humidity on Coronavirus Survival on Surfaces
Lisa M. Casanova et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2010)
An emerging role for p21-activated kinases (Paks) in viral infections
Celine Van den Broeke et al.
TRENDS IN CELL BIOLOGY (2010)
Bats are natural reservoirs of SARS-like coronaviruses
WD Li et al.
SCIENCE (2005)
Use of convalescent plasma therapy in SARS patients in Hong Kong
Y Cheng et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2005)
Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings
CM Chu et al.
THORAX (2004)
Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis
I Hamming et al.
JOURNAL OF PATHOLOGY (2004)
分享论文
